- Investing Ideas
- French Pharmaceuticals & Biotech Large Cap High Growth Potential
French Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
1 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
ABIVAX Société Anonyme
Market Cap: €10.9b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
New
ABVX
€122.10
7D
3.9%
1Y
1,708.9%
Sartorius Stedim Biotech
Market Cap: €17.4b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€173.40
7D
-2.7%
1Y
-13.5%
Eurofins Scientific
Market Cap: €12.0b
Provides various analytical testing and laboratory services worldwide.
ERF
€67.06
7D
-2.0%
1Y
12.3%